Robinson C J, Spanos E, James M F, Pike J W, Haussler M R, Makeen A M, Hillyard C J, MacIntyre I
J Endocrinol. 1982 Sep;94(3):443-53. doi: 10.1677/joe.0.0940443.
Intestinal calcium absorption and plasma levels of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) were measured in lactating and non-lacting rats and the effects of bromocriptine and exogenous prolactin treatment were evaluated. In lacting rats calcium absorption and plasma levels of parathyroid hormone, 1,25(OH)2D3 and alkaline phosphatase activity were significantly increased. Bromocriptine treatment significantly reduced the enhanced calcium absorption and levels of plasma 1,25(OH)2D3 and alkaline phosphatase but had no significant effect on plasma levels of parathyroid hormone. Prolactin administered with bromocriptine to lactating animals prevented all the changes observed with bromocriptine treatment alone. It was concluded that the increased plasma levels of prolacting during lactation lead to high plasma levels of 1,25(OH)2D3 which are responsible for the enhanced intestinal calcium absorption.
在泌乳和非泌乳大鼠中测量了肠道钙吸收和1,25 - 二羟胆钙化醇(1,25(OH)2D3)的血浆水平,并评估了溴隐亭和外源性催乳素治疗的效果。在泌乳大鼠中,钙吸收以及甲状旁腺激素、1,25(OH)2D3的血浆水平和碱性磷酸酶活性显著增加。溴隐亭治疗显著降低了增强的钙吸收以及血浆1,25(OH)2D3和碱性磷酸酶的水平,但对甲状旁腺激素的血浆水平没有显著影响。给泌乳动物同时使用溴隐亭和催乳素可防止仅用溴隐亭治疗时观察到的所有变化。得出的结论是,泌乳期间血浆催乳素水平升高导致血浆1,25(OH)2D3水平升高,而这正是肠道钙吸收增强的原因。